article thumbnail

Medication Counselling

RX Note

It consolidates and replaces four previous guideline publications: Garis Panduan Kaunseling Ubat-ubatan, 2019 Garis Panduan Pelaksanaan Kaunseling Ubat-ubatan Secara Maya/Virtual, 2021 Topical Preparations Counselling Guide for Pharmacists, 2018 Garis Panduan Kaunseling Methadone.

article thumbnail

Avatrombopag Receives FDA Approval for Treamtent of Pediatric Patients With Chronic Immune Thrompcytopenia

Pharmacy Times

Common adverse reactions in pediatric patients included viral infections, nasopharyngitis, and cough, but the drug was generally well-tolerated. In 2019, the FDA approved avatrombopag’s expanded indication for treatment of adults with chronic immune thrombocytopenia (ITP) that hasn't responded satisfactorily to a previous therapy.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

FDA approves bluebird bio’s Skysona to treat cerebral adrenoleukodystrophy

Pharmaceutical Technology

Mucositis, vomiting, nausea, febrile neutropenia, alopecia and reduced appetite among others were reported to be the most prevalent non-laboratory adverse reactions reported. In June 2019, the European Commission granted conditional marketing authorisation for bluebird bio’s Zynteglo to treat transfusion-dependent ?-thalassemia.

article thumbnail

ACMT Toxicology Visual Pearl: Making Rash Decisions

ALiEM - Pharm Pearls

The RegiSCAR (Registry of Severe Cutaneous Adverse Reactions) group suggested the following criteria for diagnosing DRESS syndrome and a point scoring system determining negative, possible, probable, or definitive DRESS syndrome [ MDCalc ]: Fever >38.5⸰C McGraw Hill; 2019. How do you diagnose DRESS syndrome?

article thumbnail

ViiV/J&J’s long-acting HIV regimen finally approved in US

pharmaphorum

It follows a surprise rejection at the end of 2019, due to the information in the dossier related to chemistry, manufacturing and controls (CMC). The FDA has approved Cabenuva, a long-acting HIV treatment from ViiV and Johnson & Johnson that keeps the virus at bay with a monthly injection instead of daily pill regimen.

article thumbnail

Lexicomp Drug Information Handbook

RX Note

Adverse Reactions (Significant): Considerations Useful for medication counselling. In early September 2019, the user interface of Lexicomp mobile application is updated. Extensive dosing information Covers dosing in paediatric, older adult and obese patients. Covers dosing in altered kidney function and hepatic impairment too.

article thumbnail

PMPRB takes jurisdiction over medicine (again) following Federal Court of Appeal remand

Pharma in Brief

The PMPRB accepted that there was a slightly elevated incidence of adverse reactions as well as higher efficacy for DIFFERIN XP when compared to DIFFERIN. This case is REASONS FOR DECISION ON REDETERMINATION ORDERED BY THE FEDERAL COURT OF APPEAL ON JUNE 28, 2019.